AstraZeneca Decision from the Netherlands and Portugal
AstraZeneca Decision from the Netherlands and Portugal. The Netherlands and Portugal limited the use of the vaccine developed by Oxford University and AstraZeneca to people over 60 years old.
While the concerns that the use of the vaccine developed by AstraZeneca and Oxford University against the corona virus in young people cause “rare blood clotting”, a new decision came from the Netherlands and Portugal on the vaccine.
Dutch Health Minister Hugo de Jonge said in a statement that the Dutch government will limit the use of the AstraZeneca vaccine to people over the age of 60, following rare cases of blood clotting.
Minister Jonge stated that people over the age of 60 who were born in 1960 or before can safely continue to receive the AstraZeneca vaccine, and that the government will offer a different vaccine to people under 60.
The Netherlands, which has ordered 12 million doses of the AstraZeneca vaccine, is among the few countries that have recently restricted the use of the vaccine after concerns about side effects.
PORTUGAL IS RESTRICTED
In a statement made by the Portuguese General Directorate of Health (DGS), it has announced that the AstraZeneca vaccine will be offered only to people over 60 years old. Henrique Melo, the coordinator of the vaccination task force, stated that the decision will only have a “small” effect on the dissemination of vaccination, and said that in Portugal, 400,000 doses of AstraZeneca vaccine were administered.
“I would like to emphasize that the aim of the vaccination campaign in Portugal is to save lives and prevent serious diseases,” DGS Director Graca Freitas said at the press conference. “This can be achieved with any vaccine approved in Portugal,” he said.
A TEMPORARY SITUATION
Freitas stated that people who received the first dose of the vaccine should remain calm because the side effects are “extremely rare”, explaining that the suspension of the vaccine for people under 60 is a temporary situation and that the situation will be re-evaluated when there is more data on the vaccine.
Portugal expects to receive another 1.4 million doses of vaccine from AstraZeneca by June, while Pfizer / BioNTech and Moderna vaccines are also being administered in the country.
IT WILL USE FOR OVER 60 YEARS OLD
Italian Health Minister Roberto Speranza announced that, in line with the opinion of the country’s Supreme Council for Health (ISS), they recommended that the controversial AstraZeneca vaccine be administered only to people over the age of 60 in parallel with other European countries.
RECOMMENDATION ‘UNDER 30’ IN THE UK
In the UK, the Medicines and Healthcare Products Regulatory Authority (MHRA) stated that the rare risk of blood clotting increased with the administration of AstraZeneca vaccine to people under the age of 30, and recommended the administration of another possible alternative vaccine to people aged 18-29.
EMA HAS MADE ANNOUNCEMENT
The European Medicines Agency (EMA) stated that there is a link between the vaccines developed by AstraZeneca against Covid-19 and blood clotting cases, but announced that this is very rare.
The EMA stated that blood coagulation should be listed as a rare side effect of the AstraZeneca vaccine. Drawing attention to the disruptions in vaccine supply, EMA emphasized that the benefits of the vaccine are more than the risks.